DIPASQUALE, Valeria
 Distribuzione geografica
Continente #
EU - Europa 1.404
NA - Nord America 1.188
AS - Asia 264
SA - Sud America 6
Totale 2.862
Nazione #
US - Stati Uniti d'America 1.186
IE - Irlanda 531
SE - Svezia 409
IT - Italia 282
CN - Cina 182
PL - Polonia 93
SG - Singapore 43
DE - Germania 29
IN - India 18
FI - Finlandia 15
AT - Austria 12
VN - Vietnam 10
ES - Italia 9
GB - Regno Unito 5
UA - Ucraina 5
HK - Hong Kong 4
MK - Macedonia 4
BR - Brasile 3
CO - Colombia 3
FR - Francia 3
ID - Indonesia 2
JP - Giappone 2
BE - Belgio 1
BG - Bulgaria 1
CA - Canada 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
MX - Messico 1
NL - Olanda 1
NP - Nepal 1
PH - Filippine 1
RO - Romania 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 2.862
Città #
Dublin 504
Chandler 355
Nyköping 214
Messina 129
Warsaw 92
Princeton 87
Ashburn 70
Beijing 51
Medford 51
Dearborn 46
Des Moines 45
Menlo Park 34
Jacksonville 31
Singapore 28
Guangzhou 22
Seattle 19
Reggio Calabria 17
Nanjing 16
Jinan 15
New York 15
Ann Arbor 14
Vienna 12
Wilmington 12
Boardman 11
Hangzhou 11
Hyderabad 11
Dong Ket 10
Rome 10
Caltagirone 9
Cambridge 8
Lappeenranta 8
Milan 8
Taizhou 8
Tianjin 8
Bremen 7
Madrid 7
Shenyang 7
Ningbo 6
Pune 6
San Mateo 6
Zhengzhou 6
Catania 5
Haikou 5
Hebei 5
San Gregorio Di Catania 5
Santa Clara 5
Bologna 4
Cagliari 4
Helsinki 4
Mascali 4
Polistena 4
Skopje 4
Fairfield 3
Fuzhou 3
Hong Kong 3
Jiaxing 3
Lancaster 3
Mogi das Cruzes 3
Norwalk 3
Redwood City 3
Bergamo 2
Changsha 2
Fort Worth 2
Genova 2
Grand Forks 2
Leawood 2
Paola 2
Redmond 2
Rimini 2
Secaucus 2
Torino 2
Trieste 2
Woodbridge 2
Yogyakarta 2
Zipaquirá 2
Bangkok 1
Bloomsbury 1
Brussels 1
Bucharest 1
Chaoyang 1
Chiusi 1
Chongqing 1
Circleville 1
Elk Grove Village 1
Elmendorf 1
Giovinazzo 1
Hamburg 1
Hefei 1
Houston 1
Karby 1
Landshut 1
Lanzhou 1
Latina 1
Meppel 1
Modica 1
Montréal 1
Nanchang 1
Nürnberg 1
Palermo 1
Peever 1
Totale 2.154
Nome #
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 93
Managing Pediatric Foreign Body Ingestions: A 10-Year Experience 86
Efficacy, safety, and pharmacokinetics of anti-TNF-α biosimilars in pediatric patients with inflammatory bowel diseases 83
null 76
Standard polymeric formula tube feeding in neurologically impaired children: A five-year retrospective study 73
Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: a report of two cases, Valeria Dipasquale, Marco Atteritano, Irene Castagna, Jlenia Fresta, Giovanni Conti 72
Inflammatory biomarkers and intellectual disability in patients with Down syndrome 71
Neuroinflammation in Autism Spectrum Disorders: Role of High Mobility Group Box 1 Protein 60
Fibers in pediatric functional gastrointestinal disorders. Practical considerations from clinical cases 58
Pseudotumor cerebri syndrome and renal diseases in the pediatric population 55
Headache and diplopia after rapid maxillary expansion: a clue to underdiagnosed pseudotumor cerebri syndrome? 55
Complementary feeding: new styles versus old myths 55
Acute Malnutrition in Children: Pathophysiology, Clinical Effects and Treatment 55
Diet and nutrition in pediatric inflammatory bowel diseases 55
Vaccination strategies in pediatric inflammatory bowel disease 54
Caregiver Social Status and Health-Related Quality of Life in Neurologically Impaired Children on Home Enteral Nutrition 54
Vaccinations and Immune Response in Celiac Disease 53
Biallelic Variants in KIF17 Associated with Microphthalmia and Coloboma Spectrum 53
Breastfeeding and IL-10 levels in children affected by cow's milk protein allergy: A restrospective study 52
Health-Related Quality of Life and Home Enteral Nutrition in Children with Neurological Impairment: Report from a Multicenter Survey 52
Surgery-related quality of life of pediatric patients with Crohn's disease 52
Effectiveness and safety of biologics in pediatric inflammatory boweldisease: Real-life data from the Sicilian Network 50
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 50
Cutaneous small-vessel vasculitis associated with paediatric ulcerative colitis: A case study and literature review 49
Laparoscopic robotic-assisted restorative proctocolectomy and ileal J-pouch-anorectal anastomosis in children 47
An overview of the clinical management of cyclic vomiting syndrome in childhood 46
Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease 46
Colectomy and health-related quality of life in children with ulcerative colitis 46
The management of colonic polyps in children: a 13-year retrospective study 46
Illegal immigration: The puzzling role of several risk factors for rhabdomyolysis 45
Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study 45
Duodenal Duplication Cysts in Children: Clinical Features and Current Treatment Choices 45
Challenges in paediatric inflammatory bowel diseases in the COVID-19 time 44
Pericarditis during infliximab therapy in paediatric ulcerative colitis 43
Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN 43
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group: Impact of the lockdown on IBD management in children 42
Clinical features and long-term outcomes in pediatric cyclic vomiting syndrome: A 9-year experience at three tertiary academic centers 42
Antiemetic Drug Use in Children: What the Clinician Needs to Know 41
Thalidomide for de novo Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis 41
Gastrointestinal symptoms in children: Primary care and specialist interface 40
Prominent and regressive brain developmental disorders associated with nance-horan syndrome 39
A loss-of-function homozygous mutation in DDX59 implicates a conserved DEAD-box RNA helicase in nervous system development and function 37
Biosimilar infliximab in paediatric inflammatory bowel disease: Efficacy, immunogenicity and safety 37
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group 37
Nutrition in pediatric gastroenterology 37
Vedolizumab-associated pulmonary manifestations in children with ulcerative colitis 36
Pouchitis in pediatric ulcerative colitis: A multicenter study on behalf of Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition 35
Appropriate age at solid introduction: is EFSA extending the individualised window on a sounding scientific evidence? 34
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 34
Premenstrual asthma: A myth or a reality? 33
Gastrointestinal and nutritional issues in children with neurological disability 32
Clinical Features and Outcomes of Paediatric Patients with Isolated Colonic Crohn's Disease 32
Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence 31
Pancreatic associated manifestations in pediatric inflammatory bowel diseases 30
Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease 30
Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications 29
Update on the classification and pathophysiological mechanisms of pediatric cardiorenal syndromes 29
Infections and malignancies risks related to TNF-α-blocking agents in pediatric inflammatory bowel diseases 28
Top-ten tips for managing nutritional issues and gastrointestinal symptoms in children with neurological impairment 28
Breastfeeding and IL-10 levels in children affected by cow's milk protein allergy: A restrospective study 28
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group 27
Management of Gastrointestinal and Nutritional Problems in Children with Neurological Impairment: A Survey of Practice 24
Bowel preparation and factors correlated with patients and parents 23
Octreotide: A Therapeutic Option for Pediatric Pseudotumor Cerebri Syndrome? 21
Pericarditis during infliximab therapy in paediatric ulcerative colitis 21
Standard and Specialized Infant Formulas in Europe: Making, Marketing, and Health Outcomes 18
Vaccination strategies in pediatric inflammatory bowel disease 16
Spontaneous reporting of adverse reactions related to proton pump inhibitors 14
Randomised controlled trial of melatonin for paediatric functional abdominal pain disorders 14
Real-life experience of infliximab biosimilar in pediatric-onset inflammatory bowel disease: data from the Sicilian Network for Inflammatory Bowel Disease 8
Different Vitamin D Supplementation Strategies in the First Years of Life: A Systematic Review 8
Genes vs environment in inflammatory bowel disease: an update 7
Real food in enteral nutrition for chronically ill children: overview and practical clinical cases 7
Early Tube Feeding Improves Nutritional Outcomes in Children with Neurological Disabilities: A Retrospective Cohort Study 6
Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease 5
Vitamin D in Prevention of Autoimmune Diseases 4
Tube Feeding in Neurologically Disabled Children: Hot Topics and New Directions 4
Clinical Course of Very Early-Onset Inflammatory Bowel Disease 2
Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population 2
Risk Factors for Complications and Disease Recurrence after Ileocecal Resection for Crohn’s Disease in Children and Adults 2
Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease 1
De Novo Crohn's Disease in Children With Ulcerative Colitis Undergoing Ileal Pouch-Anal Anastomosis: A Multicenter, Retrospective Study From the Pediatric IBD Porto Group of the ESPGHAN 1
Enhanced Recovery Care versus Traditional Care after Surgery in Pediatric Patients with Inflammatory Bowel Disease: A Retrospective Case-Control Study 1
A Systematic Review to Manage Avoidant/Restrictive Food Intake Disorders in Pediatric Gastroenterological Practice 1
Refeeding syndrome in pediatric age, an unknown disease: A narrative review 1
Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group 1
Gastrointestinal and nutritional care in pediatric neuromuscular disorders 1
Totale 3.064
Categoria #
all - tutte 14.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.619


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020181 10 1 4 1 7 45 22 8 9 44 20 10
2020/2021328 14 14 66 8 50 8 22 30 78 26 0 12
2021/2022715 2 30 8 210 53 1 25 17 34 109 39 187
2022/20231.411 108 148 56 80 78 145 23 102 605 8 36 22
2023/2024337 23 61 23 31 21 53 14 47 1 23 5 35
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 3.064